Target-directed cancer: protein-ligand interactions
Drug Target Review
NOVEMBER 1, 2023
We support the drug discovery projects of the CCDD with assay development and screening, biophysics, structural biology and recombinant protein production. With all these diverse methods we characterise protein-ligand interactions in many ways. Capivasertib (orange) bound to the kinase domain of AKT (blue).
Let's personalize your content